RecruitingPhase 1NCT05038696
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
Studying Cancer-associated retinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National University Hospital, Singapore
- Principal Investigator
- Allen Yeoh, M.DNational University Hospital, Singapore
- Intervention
- CAR T-cell therapy(biological)
- Enrollment
- 40 enrolled
- Eligibility
- 80 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Allen Yeoh Eng Juh, Singapore, Singapore
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05038696 on ClinicalTrials.govOther trials for Cancer-associated retinopathy
Additional recruiting or active studies for the same condition.